Clinical Trials

51 trials
RecentStart dateEnrollment
Phase NA × Interventional × Dementia × Clear all
NCT05637801 2026-02-05

Hope

Cognito Therapeutics, Inc.

Phase NA Active not recruiting
670 enrolled
Lymphoid

Alzheimer disease type 1, Alzheimer disease type 2, Alzheimer disease type 4, Alzheimer disease, familial, type 3, Alzheimer Disease 9, Alzheimer Disease 8, Alzheimer Disease 11, Alzheimer Disease 7, Alzheimer Disease 6, Alzheimer Disease 10, Alzheimer Disease 5, Alzheimer Disease 15, Alzheimer Disease 14, Alzheimer Disease 13, Alzheimer Disease 12, Alzheimer Disease 16, Alzheimer Disease, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

NCT02742597 2023-03-17

PACEinMM-ON

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase NA Completed
175 enrolled
GastrointestinalGenitourinaryHead & Neck

Alzheimer Disease, Anxiety Disorders, Arthritis, Arthritis, Rheumatoid, Asthma, Cardiovascular Diseases, Ischemic Attack, Transient, Colitis, Ulcerative, Crohn Disease, Dementia, Depression, Diabetes Mellitus, Diverticulum, Gastroesophageal Reflux, Heart Failure, Hepatitis, Chronic, Hyperlipidemias, Hypertension, Kidney Diseases, Neoplasms, Osteoporosis, Thyroid Diseases, Ulcer, Stroke, Pulmonary Disease, Chronic Obstructive, Bronchitis, Chronic, Irritable Bowel Syndrome, Musculoskeletal Pain